Health Care
Stories
Here you will find a selection of our articles and blogs. Please find out more about the latest trends, formulations and production in the life science industry. As science and technology are in a permanent state of motion.

Rewriting the health code
by Stefan Randl and Maaike Everts, January 2022
The Covid-19 pandemic has ushered in a new era in medicine – that of mRNA technology. But the potential of mRNA for preventing and treating a whole range of diseases reaches further to infectious diseases, cancer immunotherapy and gene therapy.

Seizing the opportunities from disruptive forces in biopharma
by Gaelle Phillips, January 2021
COVID-19 has put biopharmaceuticals in the spotlight although business analysts had been awestruck by the meteoric rise of the industry for some time.

Your biggest formulation decision
by Elisabeth Hawkings, June 2021
Find out how to choose the right development partner and solution providers for your nutraceutical products!

Value through social responsibility
by Gilles Razzauti, November 2021
Consumers are becoming more informed about their nutraceutical choices. They want more natural, organic, sustainable, pure and vegan products which are less processed and free from food additives or impurities.

Continuous manufacturing of APIs
Chemical & Engineering News
by Julia Born, October 2020
This white paper explores opportunities to accelerate development workflows, optimize purity and yield, and reduce capital investment by applying modular approaches to the continuous manufacturing of APIs or advanced intermediates under cGMP conditions.

Requirements of Safe HPAPI Manufacturing
CheManager
by Andreas Meuth, September 2020
The pharmaceutical industry is focusing increasingly on specialized drugs with new treatment modalities. Behind these substances are pharmacologically active substances (HPAPIs) that develop their biological activity at extremely low concentrations.

Aseptic filling of powder, liquid suspension and combination forms
Pharmaceutical Technology
September 2020
Get information on a review of a modular aseptic filling platform for use with complex and personalized parenteral medications in powder, liquid, suspension or combination form!

Top ten tips on formulation opportunities
by Dennis Goerges, August 2020
Successful nutraceutical manufacturers recognize that the right choice of ingredients and formulation services can make all the difference when it comes to brand preference and consumer acceptance.
-
Read more

Securing the Supply Chain
Pharmaceutical Technology
by Felicity Thomas, June 2020
The global COVID-19 pandemic has underlined the need for the pharmaceutical industry to strengthen its supply chain enabling lower costs, efficient drug development and commercialization channels.

A Welcome Change: The Benefits of Reformulation
Pharmaceutical Technology
by Felicity Thomas, May 2020
Reformulation strategies can help formulators reduce product development times, increase patient adherence, enhance brand preference, and extend the commercial life cycle of the product by using proprietary formulation technologies that are difficult to copy by potential generic competitors.

New opportunities for consumer convenience
by Lucia Heckler, April 2020
The old addage "you are what you eat" could equally be said for cell culture, because the quality of what you put into your bioreactor dictates the quality of what comes out. Discover how smart media formulations drive performance!

Excipients: matching ingredients to molecules improves functionality
Drug Development & Delivery
April 2020
In this annual report, excipient manufacturers describe how their excipient offerings improve drug release, solubility, taste, physical properties, viscosity and more for a range of molecules.

Advanced technology platforms
Chemical & Engineering News
by Dr. Dana Kralisch, April 2020
Advanced technology platforms for defining pharma-CMO relationships enable the combination of advanced technologies for complex projects such as coupling HPAPI, catalysis, cyrogenic and organometallic technologies for high potency compounds that require a complex manufacturing process.

EXCIPIENTS: MATCHING INGREDIENTS TO MOLECULES IMPROVES FUNCTIONALITY
Drug Development & Delivery Magazine
April 2020
The development of more functionalized and specialized drugs can optimize performance as well as safety and patient acceptance. Functional excipients can be used in a range of oral and parenteral dosage forms to achieve virtually any desired release profile.

Brand loyalty: customer convenients trends
by Bente Jonassen, March 2020
If you are seeking to develop or enhance a nutraceutical product targeting a specific consumer group or application area, read on to find out how you can create preferred formulations which are highly accepted and preferentially used.

Improving Bioavailability & Solubility: Understand Your Molecule
Drug Development & Delivery Magazine
March 2020
Stabilized amorphous solid dispersions (ASDs) are the most effective and widely used method for improving drug solubility, which can lead to higher bioavailability, especially when permeability is not the limiting factor. This is because in order to make an active ingredient bioavailable, a certain level of solubility in water must be achieved.
-
Read more

Qualification of a small-scale facility for ultra-HPAPIs
Speciality Chemicals Magazine
by Dr. Tim Pohlmann, February 2020
Learn more about how a facility has been qualified to handle high-potency active pharmaceutical ingredients through industrial hygiene measures, risk management and a robust hazard assessment.

LIPID NANOPARTICLE MEDIATED GENE THERAPY
Teknoscienze (TKS)
January | February 2020
The article briefly reviews the emergence of lipid nanoparticle formulations of nucleic acids from liposomal systems and the differences in formulation and manufacturing practices that have enabled clinical application.

Natural products for the satisfaction of consumer preferences
by Clarisse Binet-Gross, January 2020
Omega-3 fish oil supplements are becoming increasingly popular. However, processing fish oil into a convenient and palatable form is a major challenge and often results in consumers' needs not being met. Discover how we can help change that!

Manufacturing of Highly Potent APIs
American Pharmaceutical Review
by Nadine Bremser, January 2020
It is an important regulatory and safety requirement that the potential hazards of handling HPAPIs be identified and understood to enable the development of occupational exposure limits (OELs). Therefore, we explain their manufacture with best practice safety and containment control procedures.
Archive of publications
Manufacturing of highly potent APIs with best-practice safety and containment control procedures
American Pharmaceutical Review , September | October 2019
Development of a continuous process for organometallic reactions - a perspective
Tekno Scienze Publisher, May | June 2019
Excipients: Formulators Want Excipients for Solubility & Beyond
Drug Development & Delivery, April 2019
Improving Bioavailability & Solubility: Chemical & Physical Modification vs. Formulation Development
Drug Development & Delivery, March 2019
Outsourcing Formulation Development & Manufacturing: CDMOs Shift to Offer More Specialized Services
Drug Development & Delivery, June 2019
An Interview with Danielle Clay, Director of Global Strategic Marketing and Business Development for Injectable Drug Delivery, Evonik
American Pharmaceutical Review, February 2019
Evonik Completes Multi-Million Dollar Expansion of its CMO Capabilities for API & Advanced Intermediates
Drug Development & Delivery, September 2018
Cultural change in the Midwest - Evonik claims success in turning a Lilly drug plant into a pharmaceutical services facility
Chemical & Engineering News, March 2018
Improving Bioavailability & Solubility: A Top-Down Versus Bottom-Up Approach
Drug Development & Delivery, March 2018
Evonik Expands North American Contract Development & Manufacturing Capabilities for Advanced Injectables
Drug Development & Delivery, August 2018
Outsourcing Formulation Development & Manufacturing: CDMOs Are Innovating for 21st-Century Medicine
Drug Development & Delivery, June 2018
Development and implementation of a large-scale HPAPI manufacturing process
Tekno Scienze Publisher, September | October 2017
A 30-Year History of PLG Applications in Parenteral Controlled Drug Release
PharmTech, July 2017